PLoS ONE (Jan 2011)

Time-resolved human kinome RNAi screen identifies a network regulating mitotic-events as early regulators of cell proliferation.

  • Jitao David Zhang,
  • Cindy Koerner,
  • Stephanie Bechtel,
  • Christian Bender,
  • Ioanna Keklikoglou,
  • Christian Schmidt,
  • Anja Irsigler,
  • Ute Ernst,
  • Ozgür Sahin,
  • Stefan Wiemann,
  • Ulrich Tschulena

DOI
https://doi.org/10.1371/journal.pone.0022176
Journal volume & issue
Vol. 6, no. 7
p. e22176

Abstract

Read online

Analysis of biological processes is frequently performed with the help of phenotypic assays where data is mostly acquired in single end-point analysis. Alternative phenotypic profiling techniques are desired where time-series information is essential to the biological question, for instance to differentiate early and late regulators of cell proliferation in loss-of-function studies. So far there is no study addressing this question despite of high unmet interests, mostly due to the limitation of conventional end-point assaying technologies. We present the first human kinome screen with a real-time cell analysis system (RTCA) to capture dynamic RNAi phenotypes, employing time-resolved monitoring of cell proliferation via electrical impedance. RTCA allowed us to investigate the dynamics of phenotypes of cell proliferation instead of using conventional end-point analysis. By introducing data transformation with first-order derivative, i.e. the cell-index growth rate, we demonstrate this system suitable for high-throughput screenings (HTS). The screen validated previously identified inhibitor genes and, additionally, identified activators of cell proliferation. With the information of time kinetics available, we could establish a network of mitotic-event related genes to be among the first displaying inhibiting effects after RNAi knockdown. The time-resolved screen captured kinetics of cell proliferation caused by RNAi targeting human kinome, serving as a resource for researchers. Our work establishes RTCA technology as a novel robust tool with biological and pharmacological relevance amenable for high-throughput screening.